Advertisement
Canada markets open in 2 hours 47 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    83.90
    +0.33 (+0.39%)
     
  • Bitcoin CAD

    87,860.52
    +1,139.23 (+1.31%)
     
  • CMC Crypto 200

    1,389.10
    -7.44 (-0.53%)
     
  • GOLD FUTURES

    2,358.60
    +16.10 (+0.69%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,740.50
    +173.00 (+0.98%)
     
  • VOLATILITY

    15.63
    +0.26 (+1.69%)
     
  • FTSE

    8,110.41
    +31.55 (+0.39%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     

Stocks in play: Aequus Pharmaceuticals Inc.

Has received a receipt for its final short form base shelf prospectus. The Prospectus will allow Aequus ...

Has received a receipt for its final short form base shelf prospectus. The Prospectus will allow Aequus to offer up to $20,000,000 of common shares, preferred shares, debt securities, subscription receipts, units and warrants from time to time, in each of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, until the Prospectus expires on September 16, 2019. Aequus Pharmaceuticals Inc.